These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25462275)

  • 1. Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model.
    Olmo F; Guardia JJ; Marin C; Messouri I; Rosales MJ; Urbanová K; Chayboun I; Chahboun R; Alvarez-Manzaneda EJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Jan; 89():683-90. PubMed ID: 25462275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
    Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scorpiand-like azamacrocycles prevent the chronic establishment of Trypanosoma cruzi in a murine model.
    Olmo F; Marín C; Clares MP; Blasco S; Albelda MT; Soriano C; Gutiérrez-Sánchez R; Arrebola-Vargas F; García-España E; Sánchez-Moreno M
    Eur J Med Chem; 2013; 70():189-98. PubMed ID: 24158012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo identification of tetradentated polyamine complexes as highly efficient metallodrugs against Trypanosoma cruzi.
    Olmo F; Cussó O; Marín C; Rosales MJ; Urbanová K; Krauth-Siegel RL; Costas M; Ribas X; Sánchez-Moreno M
    Exp Parasitol; 2016 May; 164():20-30. PubMed ID: 26874306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
    Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
    Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo trypanocidal activity of some benzimidazole derivatives against two strains of Trypanosoma cruzi.
    Díaz-Chiguer DL; Márquez-Navarro A; Nogueda-Torres B; de la Luz León-Ávila G; Pérez-Villanueva J; Hernández-Campos A; Castillo R; Ambrosio JR; Nieto-Meneses R; Yépez-Mulia L; Hernández-Luis F
    Acta Trop; 2012 Apr; 122(1):108-12. PubMed ID: 22212465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of N,N'-squaramides with high in vivo efficacy and low toxicity: toward a low-cost drug against Chagas disease.
    Olmo F; Rotger C; Ramírez-Macías I; Martínez L; Marín C; Carreras L; Urbanová K; Vega M; Chaves-Lemaur G; Sampedro A; Rosales MJ; Sánchez-Moreno M; Costa A
    J Med Chem; 2014 Feb; 57(3):987-99. PubMed ID: 24410674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phthalazine derivatives containing imidazole rings behave as Fe-SOD inhibitors and show remarkable anti-T. cruzi activity in immunodeficient-mouse mode of infection.
    Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Olmo F; Yunta MJ; Sanz AM; Rosales MJ; Cano C; Campayo L
    J Med Chem; 2012 Nov; 55(22):9900-13. PubMed ID: 23043291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents.
    Mendoza-Martínez C; Correa-Basurto J; Nieto-Meneses R; Márquez-Navarro A; Aguilar-Suárez R; Montero-Cortes MD; Nogueda-Torres B; Suárez-Contreras E; Galindo-Sevilla N; Rojas-Rojas Á; Rodriguez-Lezama A; Hernández-Luis F
    Eur J Med Chem; 2015; 96():296-307. PubMed ID: 25899334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice.
    dos Santos Filho JM; Moreira DR; de Simone CA; Ferreira RS; McKerrow JH; Meira CS; Guimarães ET; Soares MB
    Bioorg Med Chem; 2012 Nov; 20(21):6423-33. PubMed ID: 23006639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.
    Moreno-Viguri E; Jiménez-Montes C; Martín-Escolano R; Santivañez-Veliz M; Martin-Montes A; Azqueta A; Jimenez-Lopez M; Zamora Ledesma S; Cirauqui N; López de Ceráin A; Marín C; Sánchez-Moreno M; Pérez-Silanes S
    J Med Chem; 2016 Dec; 59(24):10929-10945. PubMed ID: 28002965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taiwaniaquinoid and abietane quinone derivatives with trypanocidal activity against T. cruzi and Leishmania spp.
    Ramírez-Macías I; Marín C; Es-Samti H; Fernández A; Guardia JJ; Zentar H; Agil A; Chahboun R; Alvarez-Manzaneda E; Sánchez-Moreno M
    Parasitol Int; 2012 Sep; 61(3):405-13. PubMed ID: 22366342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi.
    Tempone AG; Ferreira DD; Lima ML; Costa Silva TA; Borborema SET; Reimão JQ; Galuppo MK; Guerra JM; Russell AJ; Wynne GM; Lai RYL; Cadelis MM; Copp BR
    Eur J Med Chem; 2017 Oct; 139():947-960. PubMed ID: 28881289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of artesunate against Trypanosma cruzi.
    Olivera GC; Postan M; González MN
    Exp Parasitol; 2015 Sep; 156():26-31. PubMed ID: 26024969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
    Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
    Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentamidine exerts in vitro and in vivo anti Trypanosoma cruzi activity and inhibits the polyamine transport in Trypanosoma cruzi.
    Díaz MV; Miranda MR; Campos-Estrada C; Reigada C; Maya JD; Pereira CA; López-Muñoz R
    Acta Trop; 2014 Jun; 134():1-9. PubMed ID: 24560964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy.
    Simões-Silva MR; De Araújo JS; Oliveira GM; Demarque KC; Peres RB; D'Almeida-Melo I; Batista DGJ; Da Silva CF; Cardoso-Santos C; Da Silva PB; Batista MM; Bahia MT; Soeiro MNC
    Biochem Pharmacol; 2017 Dec; 145():46-53. PubMed ID: 28870526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo trypanocidal activity of flavonoids from Delphinium staphisagria against Chagas disease.
    Marín C; Ramírez-Macías I; López-Céspedes A; Olmo F; Villegas N; Díaz JG; Rosales MJ; Gutiérrez-Sánchez R; Sánchez-Moreno M
    J Nat Prod; 2011 Apr; 74(4):744-50. PubMed ID: 21466157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of some novel 1-indanone thiazolylhydrazone derivatives as anti-Trypanosoma cruzi agents.
    Caputto ME; Ciccarelli A; Frank F; Moglioni AG; Moltrasio GY; Vega D; Lombardo E; Finkielsztein LM
    Eur J Med Chem; 2012 Sep; 55():155-63. PubMed ID: 22840495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
    García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.